RÉSUMÉ
PURPOSE: To study the short-term visual outcomes affected by the patterns of macular edema in retinal vein occlusion patients. METHODS: In a retrospective study, 33 eyes of 33 consecutive patients with macular edema from retinal vein occlusion received an intravitreal injection of bevacizumab. Macular edema was classified according to OCT patterns and the effect on visual outcome evaluated: Diffuse macular edema (DME) vs. focal macular edema (FME), and macular edema with serous retinal detachment (SRD) vs. macular edema without serous retinal detachment (non-SRD). RESULTS: Nine patients had CRVO, 24 patients had BRVO and the follow-up period was 3.6 months. In the FME group, the mean baseline BCVA was 0.61 +/- 0.34 and the final BCVA was 0.26 +/- 0.29, a difference that was statistically significant (p < 0.01). In the DME group, the mean baseline BCVA was 0.85 +/- 0.44 and the final BCVA was 0.73 +/- 0.37, a difference that was not statistically significant (p = 0.07). In the non-SRD group, the mean baseline BCVA was 0.76 +/- 0.43 and the final BCVA was 0.38 +/- 0.36, a difference that was statistically significant (p < 0.01). In the SRD group, the mean baseline BCVA was 0.73 +/- 0.40 and the final BCVA was 0.64 +/- 0.42, a difference that was not statistically significant (p = 0.07). CONCLUSIONS: Visual outcome was significantly better in the FME and non-SRD groups. The patterns of macular edema measured according to OCT were a prognostic factor for visual outcome.
Sujet(s)
Humains , Anticorps monoclonaux humanisés , Oeil , Études de suivi , Injections intravitréennes , Oedème maculaire , Décollement de la rétine , Veine centrale de la rétine , Occlusion veineuse rétinienne , Rétinal , Études rétrospectives , Tomographie par cohérence optique , BévacizumabRÉSUMÉ
Kaposis sarcoma is well recognized in patient,s with imrnunodef cienicy states such as organ trans plantation, malignancy, and acquired irnmunodeficiency syndrome(tILS). Kaposis sarcorna associated with organ transplantation is, however relatively uncomrnon in Konea. We report a case of Kaposi's sarcorna in a 23 year old male kidney recipient., who was on cyclosporine and prednisolone. The tumor involved the larynx and long as well as the skin. He was treated with radiation therapy and chemotherapy, and the dosage of immunosupressants were reduced.